| __timestamp | Arrowhead Pharmaceuticals, Inc. | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 12404000 |
| Thursday, January 1, 2015 | 57410147 | 18343000 |
| Friday, January 1, 2016 | 41454452 | 18108000 |
| Sunday, January 1, 2017 | 31690298 | 17614000 |
| Monday, January 1, 2018 | 52968505 | 35619000 |
| Tuesday, January 1, 2019 | 81048686 | 58432000 |
| Wednesday, January 1, 2020 | 128874979 | 63945000 |
| Friday, January 1, 2021 | 206342000 | 72200000 |
| Saturday, January 1, 2022 | 297307000 | 76642000 |
| Sunday, January 1, 2023 | 353188000 | 57519000 |
| Monday, January 1, 2024 | 505870000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. has demonstrated a robust increase in R&D investment, growing from approximately $23 million in 2014 to an impressive $506 million by 2024. This represents a staggering 2,100% increase, underscoring their aggressive pursuit of cutting-edge therapies.
Conversely, Evotec SE has shown a more modest growth trajectory, with R&D expenses rising from $12 million in 2014 to $77 million in 2022, marking a 540% increase. However, data for 2024 is notably absent, leaving room for speculation on their future strategies.
These trends highlight the contrasting approaches of two industry players, with Arrowhead's exponential growth suggesting a bold, high-risk strategy, while Evotec's steady increase reflects a more conservative path.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Evotec SE
Ionis Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Evotec SE
Analyzing R&D Budgets: Veracyte, Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Evotec SE
Research and Development: Comparing Key Metrics for Bausch Health Companies Inc. and Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and Novavax, Inc.
R&D Spending Showdown: Geron Corporation vs Evotec SE